6533b7d7fe1ef96bd126789c

RESEARCH PRODUCT

TGFβ-activated kinase 1 (TAK1) is activated and predicts prognosis in hepatocellular carcinoma

L UrbanskyDirk A. RidderJens U. MarquardtStefan HeinrichHagen Roland WitzelMario SchindeldeckerWilfried RothB KoehlerArndt WeinmannBeate K. Straub

subject

business.industryKinaseHepatocellular carcinomaCancer researchMedicinebusinessmedicine.diseasehttps://doi.org/10.1055/s-0039-3402228